SEPTEMBER 2024LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSFEATURED COMPANYADALLEN PHARMA18Richard Allen, Finance Director and Responsible PersonNew Product Liability Directive in Europe: Implications for the Pharmaceutical IndustryXavier Salas, Corporate Legal & Compliance Manager, Neuraxpharm17How to Drive Patient-Centred Clinical InnovationsLiselotte Hyveled, Chief Patient Officer, Board member,Novo Nordisk20UNLOCKING PATIENT ACCESS AND EMPOWERMENT: The Revolution of Remote Care at MED-EL to Transform Lives through Technological InnovationDaniel Schaudel, Head of Clinical Systems/Research & Development, MED-EL22Adopting Blockchain Technologyfor Clinical Trial ManagementTomaz Vaupotic, Senior Director, Head of Clinical & Medical Quality, Alvotech24Early Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product DevelopmentsRafael Sande, Head Operations Characterization, Large Molecules and ATMP Services, Solvias AG26Establishing a Biotech company in Europe:A mission impossible?Rüdiger Schulze, Vice President and General Manager, Germany and Central / Eastern Europe, Ultragenyx28CLINICAL TRIALSERVICES PROVIDERS IN UK - 2024TOP 5
< Page 4 | Page 6 >